Fung-AI: An AI/ML-driven pipeline for antifungal peptide discovery (opens in new tab)

Author summary As humans, we are more biologically similar to fungi than we are to bacteria or viruses. This resemblance means that it is inherently difficult to find drugs that uniquely target fungal pathogens without causing side effects in people. Consequently, there are only five approved classes of antifungal drugs on the market today. As a result of limited therapeutic options as well as the emergence of drug resistance, fungal infections are notoriously difficult to treat. Antifungal p...